Brighton Jones’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,719
Closed -$272K – 1536
2026
Q2
$272K Buy
+1,719
New +$232K 0.01% 1105
2024
Q3
– Sell
-2,240
Closed -$208K – 668
2024
Q2
$208K Buy
+2,240
New +$201K 0.01% 568
2021
Q1
– Sell
-1,609
Closed -$226K – 449
2020
Q4
$226K Buy
+1,609
New +$206K 0.01% 335

Other funds holding XBI

Brighton Jones's XBI Position: Q3 2026 in Review

Brighton Jones sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2026, closing a stake of 1,719 shares — an estimated $272K sold.

Brighton Jones first reported a position in XBI in Q4 2020 and held it in 3 quarters. The position peaked at $272K in Q2 2026. 959 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Brighton Jones reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2026 after selling out during the quarter.
  • Brighton Jones sold 1,719 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $272K.
  • Brighton Jones first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and held it in 3 quarters.
  • Brighton Jones's State Street SPDR S&P Biotech ETF position peaked at $272K in Q2 2026.
  • 959 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.